• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream

    1/20/26 7:00:00 AM ET
    $CLNN
    $DEVS
    $DGXX
    $IMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance/Investors Services
    Finance
    Get the next $CLNN alert in real time by email

    MIAMI, Jan. 20, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 89th Emerging Growth Conference on January 21 & 22, 2026.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1 - Wednesday

    January 21, 2026

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Radiopharm Theranostics, Ltd. (NASDAQ:RADX) (ASX: RAD)

    Keynote speaker: Riccardo Canevari-MD, CEO & Director

    9:40 – 10:10

    OptiumBank Holdings, Inc. (NYSE:OPHC)

    Keynote speaker: Moishe Gubin, Chairman 

    10:15 – 10:45

    White Gold Corp. (TSX.V: WGO) (OTCQX:WHGOF)

    Keynote speaker: David D'Onofrio, Chief Executive Officer  

    10:50 – 11:20

    Thiogenesis Therapeutics, Corp. (TSXV:TTI) (OTCQX:TTIPF)

    Keynote speaker: Brook Riggins, CFO

    12:00 – 12:30

    Silicon Metals Corp. (OTC:SLCNF) (CSE:SI) (FSE: X6U)

    Keynote speakers: Morgan Good, CEO & Raymod Wladichuk, COO

    12:35 – 1:05

    DevvStream Corp. (NASDAQ:DEVS)

    Keynote speakers: Sunny Trinh, CEO, & Carl M. Stanton, Chairman

    1:10 – 1:40

    Coelacanth Energy Inc. (OTC:CEIEF) (TSXV:CEI)

    Keynote speaker: Robert J. Zakresky, President & CEO

    1:55 – 2:05

    Highland Copper Company Inc. (OTCQB:HDRSF) (TSXV:HI)

    Keynote speaker: Barry O'Shea, CEO

    2:10 – 2:20

    West Red Lake Gold Mines Ltd. (OTCQB:WRLGF) (TSXV:WRLG)

    Keynote Speaker: Gwen Preston, Vice President, Communications

    2:25 – 2:35

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Chris Holden, VP Corporate Development

    2:40 – 2:50

    iMetal Resources, Inc. (OTCQB:IMRFF) (TSXV:IMR)

    Keynote speaker: Saf Dhillon – CEO, President & Director

    2:55 – 3:05

    Questcorp Mining, Inc. (OTCQB:QQCMF) (CSE:QQQ)

    Keynote speaker: Saf Dhillon – CEO, President & Director

    3:10 – 3:20

    Clene Inc., (NASDAQ:CLNN)

    Keynote speakers: Rob Etherington, President / CEO

    3:40 – 3:50

    Kneat.com, Inc., (OTCQX:KSIOF) (TSX:KSI)

    Keynote speaker: Edmund Ryan, CEO

    3:55 – 4:05

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant



    4:10 – 4:20

    Stallion Uranium Corp. (OTCQB:STLNF) (TSXV:STUD) 

    Keynote speaker: Darren Slugoski, VP Exploration



    4:25 – 4:55

    Cobalt Blue Holdings (OTC:CBBHF) (ASX: COB)

    Keynote speaker: Andrew Tong, CEO & Managing Director

    Day 2 – Thursday

    January 22, 2026

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Digi Power X, Inc. (NASDAQ:DGXX)

    Keynote speaker: Edward Karr, Capital Markets & IR Advisor

    9:40 – 10:10

    Graphene Manufacturing Group, Ltd. (OTCQX:GMGMF) (TSXV:GMG)

    Keynote speaker: Craig Nicol, Founder, MD, CEO & Director

    10:50 – 11:20

    Triumph Gold Corp. (TSXV:TIG) (OTC:TIGCF)

    Keynote speaker: John Anderson, CEO

    11:25 – 11:55



    12:00 – 12:30

    ZenaTech (NASDAQ:ZENA)

    Keynote speaker: Linda Montgomery, Vice President, Corporate Development

    12:35 – 1:05

    MetalSource Mining Inc. (CSE:MSM) (OTCQB:SFRIF)

    Keynote speaker: Joseph Cullen, President / CEO

    1:10 – 1:40

    First Phosphate Corp. (CSE:PHOS) (OTCQX:FRSPF)

    Keynote speaker: John Passalacqua, CEO

    1:45 – 2:15

    Tiger Gold Corp. (TSXV:TIGR)

    Keynote speaker: Fraser Macdougall, Director

    2:40 – 2:50

    Immuron Limited (NASDAQ:IMRN)

    Keynote speaker: Steve Lydeamore, CEO

    2:55 – 3:05

    Autris (OTCID: AUTR)

    Keynote speakers: Don Morrison, CFO, & Patrick Heibert, CEO



    3:10 - 3:20

    Surface Metals Inc. (OTCQB:SURMF) (CSE:SUR) 

    Keynote speaker: Steve Hanson, President & CEO

    3:25 – 3:35

    CopAur Minerals, Inc. (OTCQB:COPAF) (TSXV:CPAU)

    Keynote speaker: Andrew Neale – CEO

    3:40 – 3:50

    Mawson Infrastructure Group, Inc. (NASDAQ:MIGI)

    Keynote speaker: Kaliste Saloom, Interim CEO

    3:55 – 4:05

    StrikePoint Gold, Inc.'s (OTCQB:STKXF) (TSXV:SKP)

    Keynote speaker: Michael Gregory Allen, CEO, President & Director

    4:10 – 4:20

    Tivic Health Systems, Inc.'s (NASDAQ:TIVC)

    Keynote speaker: Jennifer Ernst, Co-Founder, CEO

    4:25 – 4:55

    SBC Medical Group Holdings, Inc. (NASDAQ:SBC)

    Keynote speakers: Stephen Rodgers, Head of Global Planning and Strategy & Hikaru Fukui, Head of Investor Relations

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $CLNN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLNN
    $DEVS
    $DGXX
    $IMRN

    CompanyDatePrice TargetRatingAnalyst
    SBC Medical Group Holdings Incorporated
    $SBC
    3/6/2026$8.00Buy
    BTIG Research
    Digi Power X Inc. Subordinate Voting Shares
    $DGXX
    9/2/2025$3.50Buy
    Alliance Global Partners
    ZenaTech Inc.
    $ZENA
    6/16/2025$9.00Buy
    Maxim Group
    Radiopharm Theranostics Limited
    $RADX
    3/12/2025$15.00Buy
    B. Riley Securities
    OptimumBank Holdings Inc.
    $OPHC
    5/23/2024$5.25Neutral
    Compass Point
    Clene Inc.
    $CLNN
    10/4/2022Outperform → Perform
    Oppenheimer
    Clene Inc.
    $CLNN
    7/18/2022$16.00Buy
    H.C. Wainwright
    Clene Inc.
    $CLNN
    5/2/2022$10.00Buy
    Canaccord Genuity
    More analyst ratings

    $CLNN
    $DEVS
    $DGXX
    $IMRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

    On track to share data from first two dose levels in 2H 2026 Targeting KLK3 and leveraging the dual emission of Tb161 represents an innovative approach for radiotherapies in Prostate Cancer Preclinical proof-of-concept mouse xenografts demonstrated RAD 402's strong tumor targeting with minimal bone/marrow uptake and expected hepatic clearance SYDNEY, March 27, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that the first patient has been dosed in its first-in-human Phase 1 clinical tria

    3/27/26 7:00:00 AM ET
    $RADX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results

    Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

    3/27/26 6:40:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    ZenaTech to Present its Latest Drone Interceptors, Counter-UAS Defense System, ZenaDrone, and Zena AI Developments at Upcoming Investor Conferences and Industry Events

    VANCOUVER, British Columbia, March 26, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (NASDAQ:ZENA) (FSE: 49Q) (BMV:ZENA) ("ZenaTech"), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces that its executive teams will participate in a series of high-profile investor conferences and meetings at major drone industry events during the coming months. These events bring together a variety of institutional investors, fund managers, family offices, retail investors, and defense and drone industry experts to explore innovative emerging investment opportunities, innovative companies, and t

    3/26/26 8:15:00 AM ET
    $ZENA
    Computer Software: Prepackaged Software
    Technology

    $CLNN
    $DEVS
    $DGXX
    $IMRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Endeavor Blockchain, Llc bought $192,502 worth of shares (42,100 units at $4.57), decreasing direct ownership by 100% to 4,397 units (SEC Form 4)

    4 - Mawson Infrastructure Group Inc. (0001218683) (Issuer)

    1/30/26 7:58:02 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    Large owner Endeavor Blockchain, Llc bought $290,400 worth of shares (60,000 units at $4.84), increasing direct ownership by 4% to 1,460,000 units (SEC Form 4)

    4 - Mawson Infrastructure Group Inc. (0001218683) (Issuer)

    1/26/26 7:22:56 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    Large owner Endeavor Blockchain, Llc bought $4,388,681 worth of shares (801,279 units at $5.48) (SEC Form 4)

    4 - Mawson Infrastructure Group Inc. (0001218683) (Issuer)

    1/22/26 5:47:16 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    $CLNN
    $DEVS
    $DGXX
    $IMRN
    SEC Filings

    View All

    SEC Form 6-K filed by Radiopharm Theranostics Limited

    6-K - Radiopharm Theranostics Ltd (0001949257) (Filer)

    3/27/26 8:00:18 AM ET
    $RADX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by SBC Medical Group Holdings Incorporated

    10-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    3/27/26 7:31:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    3/27/26 6:50:43 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $CLNN
    $DEVS
    $DGXX
    $IMRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ugwumba Chidozie

    4 - Clene Inc. (0001822791) (Issuer)

    3/26/26 5:39:47 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Brown Neville

    3 - ZenaTech, Inc. (0001997403) (Issuer)

    3/26/26 4:12:17 PM ET
    $ZENA
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Jeyapaul Jaganathan

    4 - Digi Power X Inc. (0001854368) (Issuer)

    3/25/26 5:30:35 PM ET
    $DGXX
    Finance: Consumer Services
    Finance

    $CLNN
    $DEVS
    $DGXX
    $IMRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on SBC Medical Group with a new price target

    BTIG Research initiated coverage of SBC Medical Group with a rating of Buy and set a new price target of $8.00

    3/6/26 8:35:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Alliance Global Partners initiated coverage on Digi Power X Inc. with a new price target

    Alliance Global Partners initiated coverage of Digi Power X Inc. with a rating of Buy and set a new price target of $3.50

    9/2/25 8:13:53 AM ET
    $DGXX
    Finance: Consumer Services
    Finance

    Maxim Group initiated coverage on ZenaTech with a new price target

    Maxim Group initiated coverage of ZenaTech with a rating of Buy and set a new price target of $9.00

    6/16/25 8:13:15 AM ET
    $ZENA
    Computer Software: Prepackaged Software
    Technology

    $CLNN
    $DEVS
    $DGXX
    $IMRN
    Leadership Updates

    Live Leadership Updates

    View All

    SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the appointment of Sheng-FU Hsiao as Chief Technology Officer (CTO), effective March 1, 2026. This appointment aligns with the Company's 2026 management strategy, "Sophistication of Management Structure through AI and DX," and strengthens its leadership team to accelerate technological transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302064873/en/SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging

    3/2/26 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Military UAV Sector Forecast to Surpass $40+ Billion as Modern Warfare Evolves

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Unmanned aerial vehicles (UAVs), commonly known as drones, have become a transformative technology in modern defense and military operations, reshaping strategies from reconnaissance to precision strike capabilities. Military drones offer armed forces enhanced situational awareness, reduced risk to personnel, and cost-efficient mission profiles across surveillance, target acquisition, logistics, and electronic warfare. As autonomous systems incorporating artificial intelligence and advanced sensor suites continue to mature, they are increasingly integral to networked battlefield operations and force multiplie

    2/19/26 8:30:00 AM ET
    $NOC
    $PRZO
    $UAVS
    Industrial Machinery/Components
    Industrials
    Military/Government/Technical
    Aerospace

    Digi Power X Provides Letter to Shareholders on 2025 Highlights and Strategic Update

    MIAMI, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. ("Digi Power X" or the "Company") (NASDAQ:DGXX, TSXV:DGX), an innovative energy infrastructure company, is pleased to announce the release of the following letter to its shareholders by Michel Amar, Chairman and Chief Executive Officer. Dear Fellow Shareholders, 2025 was a transformational year for Digi Power X, as we continue executing on our strategy to evolve from a solely digital asset mining-focused business into a power-backed AI infrastructure and Tier-3 data-center platform positioned to serve the accelerating global demand for AI compute, while still maintaining our digital asset mining business. Strategic Transformatio

    12/24/25 7:30:00 AM ET
    $DGXX
    Finance: Consumer Services
    Finance

    $CLNN
    $DEVS
    $DGXX
    $IMRN
    Financials

    Live finance-specific insights

    View All

    SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results

    Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

    3/27/26 6:40:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results

    IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. market open on March 27, 2026.  Management will host an earnings conference call on March 27, 2026, at 8:30 a.m. Eastern Time to discuss the Company's financial performance, operational highlights, and key priorities for 2026. A question‑and‑answer session with analysts and investors will follow the prepared remark

    3/13/26 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Defense Sector Turns to Drone-as-a-Service as Military Forces Seek Faster, Smarter Intelligence Solutions

    Growing reliance on real-time intelligence, surveillance, and reconnaissance is accelerating demand for scalable drone service platforms across defense operations worldwideNEW YORK, March 12, 2026 /CNW/ -- Market News Updates News Commentary -  Drones are becoming a much bigger part of modern defense operations, and a growing trend within this space is Drone-as-a-Service (DaaS). Instead of militaries buying, maintaining, and operating every drone themselves, they can now work with specialized providers that supply the drones, pilots, software, and data analytics as a service. This approach allows defense organizations to quickly deploy drone capabilities for missions such as surveillance, re

    3/12/26 9:00:00 AM ET
    $EH
    $ONDS
    $UAVS
    Aerospace
    Industrials
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $CLNN
    $DEVS
    $DGXX
    $IMRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Clene Inc.

    SC 13G/A - Clene Inc. (0001822791) (Subject)

    11/14/24 3:32:55 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Clene Inc.

    SC 13G - Clene Inc. (0001822791) (Subject)

    11/14/24 3:26:45 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Mawson Infrastructure Group Inc.

    SC 13D/A - Mawson Infrastructure Group Inc. (0001218683) (Subject)

    11/4/24 4:30:02 PM ET
    $MIGI
    Finance: Consumer Services
    Finance